Laboratory of Choice
Children are not things to be molded but are people to be unfolded.
Science-first leaders whose compassion for healthcare providers and patients is incomparable.
Curabitur arcu erat, accumsan id imperdiet et, porttitor at sem. Nulla porttitor accumsan tincidunt.
Molecular Diagnostics
Genesis Expanded Respiratory Panel
The Genesis Expanded Respiratory Panel uses polymerase chain reaction (PCR) technology to serve as a frontline diagnostic test, quickly informing the healthcare provider of Influenza, RSV, Mycoplasmas, Legionella pneumophila, and many others. The Genesis Expanded Respiratory Panel delivers the rapid, targeted clinical results that drive the most accurate diagnoses and therapies for patients. Multiplexed respiratory panel results have been shown to significantly reduce ICU days1 and the duration of antibiotic use2. Additionally, the increased certainty of viral diagnoses also ensures adherence to current antibiotic stewardship directives, reducing the likelihood of antibiotic resistance and patient morbidity3. The Genesis Expanded Respiratory Panel optimizes patient management with clinically actionable results and measurably improves patient outcomes.
GLM Expanded Respiratory Panel
Bacteria
- Bordetella (parapertussis, bronchiseptica)
- Bordetella pertussis
- Chlamydophila pneumoniae
- Haemophilus influenzae
- Klebsiella pneumoniae
- Legionella pneumophila
- Mycoplasma pneumoniae
- Streptococcus pneumoniae
- Staphylococcus aureus
Viruses
- Adenovirus
- Human Bocavirus
- Human Metapneumovirus
- Coronavirus 229E
- Coronavirus HKU1
- Coronavirus NL63
- Coronavirus OC43
- Enterovirus
- HHV3 (Varicella Zoster Virus)
- HHV4 (Epstein Barr Virus)
- HHV5 (Cytomegalovirus)
- HHV6 (Human Herpesvirus 6)
- Influenza A H1-2009
- Influenza A H3
- Influenza A pan
- Influenza B
- Parainfluenza Virus 1
- Parainfluenza Virus 2
- Parainfluenza Virus 3
- Parainfluenza Virus 4
- Respiratory Syncytial Virus (RSV) A
- Respiratory Syncytial Virus (RSV) B
- Rhinovirus
Molecular Diagnostics
Molecular Diagnostics
Keep up-to-date with Genesis Labs.
46th Annual New York Course Conference
sean@rizco.com2022-12-02T15:58:47+00:00December 2, 2022|
Florida Digestive Diseases Update 2022
sean@rizco.com2022-12-02T16:49:20+00:00December 2, 2022|
Post ACG Conference
genesislabs222022-11-18T14:40:41+00:00November 17, 2022|
References
- Rogers B, Shankar P, Jerris R, Kotzbauer D, Anderson E, Watson R, O’Brien L, Uwindatwa F, McNamara K, Bost J. Impact of a Rapid Respiratory Panel Test on Patient Outcomes. Arch. Path. & Lab. Med. 2015;139(5): 636-41.
- Martinez R, Kay HE, Scicchitano LM, Wolk DM. Implementation of Non-Batched Respiratory Virus Assay Significantly Impacts Patient Outcomes in the ICU. Clinical Virology Symposium, Poster #C-368, May 2016
- Barlam, T. F., Cosgrove, S. E., Abbo, L. M., MacDougall, C., Schuetz, A. N., Septimus, E. J., … & Hamilton, C. W. (2016). Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clinical Infectious Diseases, 62(10), e51-e77.